Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boucher

Showing results (361-370 of 377) with videos related to

Pageof 38
Sort By:
Diabetologia|April 1, 1983
A collaborative study of the measurement of glycosylated haemoglobin by several methods in seven laboratories in the United KingdomB J Boucher, J M Burrin, B J Gould, et al.
Journal of Parkinson'S Disease|December 24, 2019
Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD StudyCarmen Martin-Ruiz, Caroline H Williams-Gray, Alison J Yarnall, et al.
BMC Public Health|October 25, 2013
The effects of vitamin D₂ or D₃ supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trialRavi K Menon, Anna P Rickard, Nasima Mannan, et al.
Immunology|January 31, 2009
1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infectionAnna Coussens, Peter M Timms, Barbara J Boucher, et al.
Journal of Medicinal Chemistry|May 19, 2021
Re-emerging Aspartic Protease Targets: Examining <i>Cryptococcus neoformans</i> Major Aspartyl Peptidase 1 as a Target for Antifungal Drug DiscoveryRobin Kryštůfek, Pavel Šácha, Jana Starková, et al.
Archives of Toxicology|July 19, 2016
Vitamin D and chronic diseases: the current state of the artGiovanna Muscogiuri, Barbara Altieri, Cedric Annweiler, et al.
Mbio|October 31, 2025
Functional insight into cyclin-dependent kinase (CDK)7 via chemical inhibition of the priority fungal pathogen <i>Cryptococcus neoformans</i>Pooja Sethiya, Desmarini Desmarini, Bethany Grace Bowring, et al.
Diabetes, Obesity & Metabolism|December 25, 2015
Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trialN G Forouhi, R K Menon, S J Sharp, et al.
Dermato-Endocrinology|March 13, 2010
Open letter to IARC Director Christopher P. Wild-Re: IARC Working Group Report 5: Vitamin D and CancerCedric F Garland, William B Grant, Barbara J Boucher, et al.
European Journal of Endocrinology|November 4, 2015
Interactions between uncoupling protein 2 gene polymorphisms, obesity and alcohol intake on liver function: a large meta-analysed population-based studyKarani S Vimaleswaran, Alana Cavadino, Niek Verweij, et al.
Pageof 38

Showing results (361-370 of 377) with videos related to

Sort By:
Pageof 38
Diabetologia|April 1, 1983
A collaborative study of the measurement of glycosylated haemoglobin by several methods in seven laboratories in the United KingdomB J Boucher, J M Burrin, B J Gould, et al.
Journal of Parkinson'S Disease|December 24, 2019
Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD StudyCarmen Martin-Ruiz, Caroline H Williams-Gray, Alison J Yarnall, et al.
BMC Public Health|October 25, 2013
The effects of vitamin D₂ or D₃ supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trialRavi K Menon, Anna P Rickard, Nasima Mannan, et al.
Immunology|January 31, 2009
1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infectionAnna Coussens, Peter M Timms, Barbara J Boucher, et al.
Journal of Medicinal Chemistry|May 19, 2021
Re-emerging Aspartic Protease Targets: Examining <i>Cryptococcus neoformans</i> Major Aspartyl Peptidase 1 as a Target for Antifungal Drug DiscoveryRobin Kryštůfek, Pavel Šácha, Jana Starková, et al.
Archives of Toxicology|July 19, 2016
Vitamin D and chronic diseases: the current state of the artGiovanna Muscogiuri, Barbara Altieri, Cedric Annweiler, et al.
Mbio|October 31, 2025
Functional insight into cyclin-dependent kinase (CDK)7 via chemical inhibition of the priority fungal pathogen <i>Cryptococcus neoformans</i>Pooja Sethiya, Desmarini Desmarini, Bethany Grace Bowring, et al.
Diabetes, Obesity & Metabolism|December 25, 2015
Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trialN G Forouhi, R K Menon, S J Sharp, et al.
Dermato-Endocrinology|March 13, 2010
Open letter to IARC Director Christopher P. Wild-Re: IARC Working Group Report 5: Vitamin D and CancerCedric F Garland, William B Grant, Barbara J Boucher, et al.
European Journal of Endocrinology|November 4, 2015
Interactions between uncoupling protein 2 gene polymorphisms, obesity and alcohol intake on liver function: a large meta-analysed population-based studyKarani S Vimaleswaran, Alana Cavadino, Niek Verweij, et al.
Pageof 38